Novel high dose rate lip brachytherapy technique to improve dose homogeneity and reduce toxicity by customized mold

Radiation Oncology

Amichay Meirovitz¹  Itzhak Orion²  Jeffrey Weinberger³  Sarit Kadouri¹  Ninel Voskoboinik¹  Mordechay Sela⁴  Limor Appelbaum¹  Jon Feldman² 

[1] Oncology Department, Radiation Therapy Unit, Hadassah – Heberew University Medical Center, Jerusalem (9112001), Israel;Department of Nuclear Engineering, Ben Gurion University of the Negev, Beer Sheva (84105), Israel;Department of Otolaryngology, Hadassah – Heberew University Medical Center, Jerusalem (9112001), Israel;Maxillofacial Rehabilitation department, Hadassah – Heberew University Medical Center, Jerusalem (9112001), Israel

关键词: Customized mold technique;    HDR;    SCC;    Lip;    Brachytherapy;   

Others  :  1150426
DOI  :  10.1186/s13014-014-0271-x

 received in 2013-11-28, accepted in 2014-11-22,  发布年份 2014

【 摘 要 】

Purpose/Objectives

The purpose of this study is to describe a novel brachytherapy technique for lip Squamous Cell Carcinoma, utilizing a customized mold with embedded brachytherapy sleeves, which separates the lip from the mandible, and improves dose homogeneity.

Materials and methods

Seven patients with T2 lip cancer treated with a “sandwich” technique of High Dose Rate (HDR) brachytherapy to the lip, consisting of interstitial catheters and a customized mold with embedded catheters, were reviewed for dosimetry and outcome using 3D planning. Dosimetric comparison was made between the “sandwich” technique to “classic” – interstitial catheters only plan. We compared dose volume histograms for Clinical Tumor Volume (CTV), normal tissue “hot spots” and mandible dose. We are reporting according to the ICRU 58 and calculated the Conformal Index (COIN) to show the advantage of our technique.

Results

The seven patients (ages 36–81 years, male) had median follow-up of 47 months. Four patients received Brachytherapy and External Beam Radiation Therapy, 3 patients received brachytherapy alone. All achieved local control, with excellent esthetic and functional results. All patients are disease free.

The Customized Mold Sandwich technique (CMS) reduced the high dose region receiving 150% (V150) by an average of 20% (range 1–47%), The low dose region (les then 90% of the prescribed dose) improved by 73% in average by using the CMS technique. The COIN value for the CMS was in average 0.92 as opposed to 0.88 for the interstitial catheter only. All differences (excluding the low dose region) were statistically significant.

Conclusion

The CMS technique significantly reduces the high dose volume and increases treatment homogeneity. This may reduce the potential toxicity to the lip and adjacent mandible, and results in excellent tumor control, cosmetic and functionality.

【 授权许可】

   
2014 Feldman et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Ferlay J, Soerjomataram I, Ervik MDR, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, Lyon, France; 2013.
• [2]Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, Forman D, Bray F: Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013, 49(6):1374-1403.
• [3]Moore S, Johnson N, Pierce A, Wilson D: The epidemiology of lip cancer: a review of global incidence and aetiology. Oral Dis 1999, 5(3):185-195.
• [4]de Visscher JG, Botke G, Schakenraad JA, van der Waal I: A comparison of results after radiotherapy and surgery for stage I squamous cell carcinoma of the lower lip. Head Neck 1999, 21(6):526-530.
• [5]McCombe D, MacGill K, Ainslie J, Beresford J, Matthews J: Squamous cell carcinoma of the lip: a retrospective review of the Peter MacCallum Cancer Institute experience 1979–88. Aust N Z J Surg 2000, 70(5):358-361.
• [6]Stranc MF, Fogel M, Dische S: Comparison of lip function: surgery vs radiotherapy. Br J Plast Surg 1987, 40(6):598-604.
• [7]Coppit GL, Lin DT, Burkey BB: Current concepts in lip reconstruction. Curr Opin Otolaryngol Head Neck Surg 2004, 12(4):281-287.
• [8]Feuvret L, Noel G, Mazeron JJ, Bey P: Conformity index: a review. Int J Radiat Oncol Biol Phys 2006, 64(2):333-342.
• [9]Harrison LB: Applications of brachytherapy in head and neck cancer. Semin Surg Oncol 1997, 13(3):177-184.
• [10]Yamazaki H, Yoshida K, Yoshioka Y, Shimizutani K, Furukawa S, Koizumi M, Ogawa K: High dose rate brachytherapy for oral cancer. J Radiat Res 2013, 54(1):1-17.
• [11]Guinot JL, Arribas L, Tortajada MI, Crispín V, Carrascosa M, Santos M, Mut A, Vendrell JB, Pesudo C, Chust ML: From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications. Brachytherapy 2012, 12(6):528-534.
• [12]Rovirosa-Casino A, Planas-Toledano I, Ferre-Jorge J, Oliva-Diez JM, Conill-Llobet C, Arenas-Prat M: Brachytherapy in lip cancer. Med Oral Patol Oral Cir Bucal 2006, 11(3):E223-E229.
• [13]Finestres-Zubeldia F, Guix-Melcior B, Cloquell-Damian A, Chimenos-Kustner E, Tello-Luque JI: Treatment of the carcinoma of the lip through high dose rate brachitherapy. Med Oral Patol Oral Cir Bucal 2005, 10(1):21-24. 17–20
• [14]Lock M, Cao JQ, D’Souza DP, Hammond JA, Karnas S, Lewis C, Venkatesan VM, Whiston E, Yau G, Yu E, Gilchrist J, Rodrigues GB: Brachytherapy with permanent gold grain seeds for squamous cell carcinoma of the lip. Radiother Oncol 2011, 98(3):352-356.
• [15]Elhanafy OA, Migahed MD, Sakr HA, Ellithy M, Das RK, Odau HJ, Thomadsen BR: Comparison of two planning systems for HDR brachytherapy gynecological application. J Appl Clin Med Phys 2001, 2(3):114-120.
• [16]Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS: Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 1995, 22(2):209-234.
• [17]International Commission on Radiation Units and Measurements: ICRU 58 (Dose and Volume Specification for Reporting Interstitial Therapy), by International Commission on radiation units and measurements. International Commission on Radiation Units and Measurements, Bethesda, MD; 1997.
• [18]Baltas D, Kolotas C, Geramani K, Mould RF, Ioannidis G, Kekchidi M, Zamboglou N: A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 1998, 40(2):515-524.